Related Experiment Video
Updated: Aug 19, 2025

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
Published on: April 19, 2024
Exploring parental cystic fibrosis disclosure to well children
Amanda Boyer1, Karen Raraigh2, Stephanie Riley3
1University of Maryland School of Medicine, Baltimore, Maryland, USA.
Insights
Parents of children with cystic fibrosis (CF) openly discuss medical aspects of the disease with well siblings, starting around age five. Parental knowledge of CF did not influence disclosure topics with healthy children.
Area of Science:
- Genetics
- Pediatrics
- Psychology
Background:
- Cystic fibrosis (CF) is a chronic genetic illness impacting multiple organ systems.
- Disclosure of a sibling's CF diagnosis to well children is understudied.
- The relationship between parental CF knowledge and disclosure practices is unevaluated.
Purpose of the Study:
- Assess parental understanding of CF.
- Identify common topics and discussion frequency regarding CF with well children.
- Examine associations between parental CF knowledge and disclosure aspects.
Main Methods:
- Anonymous online survey distributed through CF support organizations.
- Participants: parents with at least one child with CF and one without.
- Data collected on disclosure timing, topics, and parental CF knowledge.
Main Results:
- Disclosure typically begins around 5.4 years old.
- Medical concerns and treatment were the most frequently discussed and important topics.
- Financial impact was discussed by fewer parents and ranked as least important.
- Parents demonstrated high CF knowledge (mean score 8.9/10).
- No associations found between parental knowledge, education, income, and disclosure topics.
Conclusions:
- Parents are knowledgeable about CF and prioritize discussing medical aspects with well siblings.
- Parental CF knowledge does not appear to influence the topics disclosed to well children.
- Findings can inform healthcare professionals assisting families with disclosure strategies.
Abstract:
Cystic fibrosis (CF), a genetic disease and chronic illness, affects multiple organ systems and requires exceptional medical care and treatment. Few studies have assessed the diagnosis disclosure process to well children when their sibling(s) have CF, and none have evaluated the association between parental knowledge of CF and the disclosure of CF. The objectives of this study were to assess parental understanding of CF, demonstrate the most commonly shared topics and their frequencies of discussion with well children, and identify associations between parental understanding of CF and aspects of the disclosure process to well children. Parents were recruited from CF support organizations and asked to complete an online, anonymous survey. Individuals were eligible to participate in the study if they had at least one living child with CF and at least one living child without CF. Completed surveys from 48 individuals revealed that most parents began discussing a sibling's diagnosis of CF with the first-born well child at 5.4 years old. Topics related to CF were discussed openly and as needed with their well children (n = 44). The most frequently discussed topic, and the topic ranked most important (1.93 of 5, SD: 1.17) by 40 participants (90.9%), was medical concerns and treatment for CF. Fewer parents (n = 18, 40.9%) reported discussing the financial impact of CF, and many ranked this as least important to share (4.64 of 5, SD: 0.75). The CF knowledge assessment revealed that participants were well-informed about CF, with a mean total score of 8.9/10 (SD: 0.91). There were no associations between CF knowledge assessment scores, education level, income, and the topics discussed with well children. These results can be utilized by genetic counselors and other healthcare specialists in discussion with parents about the disclosure process of a diagnosis of CF to well children.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Cystic Fibrosis: Management
Sinus disease and chronic...
Sex-linked Disorders
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...

